Northwest Investment Counselors’s Regeneron Pharmaceuticals REGN Stock Holding History

Northwest Investment Counselors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$193K	Buy	+184	New	+$205K	0.04%	151
2024 Q2	–	Sell	-184	Closed	-$177K	–	418
2024 Q1	$177K	Buy	+184	New	+$175K	0.04%	147
2023 Q4	–	Sell	-188	Closed	-$155K	–	435
2023 Q3	$155K	Hold	188	–	–	0.04%	157
2023 Q2	$135K	Buy	188 +4	+2%	+$3.08K	0.04%	163
2023 Q1	$151K	Sell	184 -24	-12%	-$18.1K	0.04%	165
2022 Q4	$150K	Buy	208 +194	+1,386%	+$143K	0.04%	169
2022 Q3	$10K	Hold	14	–	–	﹤0.01%	365
2022 Q2	$8K	Hold	14	–	–	﹤0.01%	391
2022 Q1	$10K	Hold	14	–	–	﹤0.01%	390
2021 Q4	$9K	Buy	+14	New	+$8.61K	﹤0.01%	371
2021 Q2	–	Sell	-14	Closed	-$7K	–	364
2021 Q1	$7K	Buy	+14	New	+$6.82K	﹤0.01%	402
2020 Q4	–	Sell	-14	Closed	-$8K	–	363
2020 Q3	$8K	Buy	+14	New	+$8.49K	﹤0.01%	349
2019 Q4	–	Sell	-14	Closed	-$4K	–	417
2019 Q3	$4K	Buy	+14	New	+$4.14K	﹤0.01%	460

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northwest Investment Counselors's REGN Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2024: 184 shares worth $193K. The stake represents 0.04% of the portfolio and ranks #151 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in REGN as recently as Q1 2024.

Northwest Investment Counselors first reported a position in REGN in Q3 2019 and has held it in 13 quarters since. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

Northwest Investment Counselors held 184 shares of Regeneron Pharmaceuticals worth $193K as of Q3 2024.
Regeneron Pharmaceuticals was a new Northwest Investment Counselors position in Q3 2024.
Regeneron Pharmaceuticals made up 0.04% of Northwest Investment Counselors's portfolio in Q3 2024, its #151 holding.
Northwest Investment Counselors first reported a position in Regeneron Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.